Skip to main content
Equibles

MERCER GLOBAL ADVISORS INC /ADV

Position in MYGN — Myriad Genetics Inc

CIK 853758 DENVER, CO
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$416,578
+$255,006 QoQ
Shares Held
72,956
+103.2% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 196 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 25% Shared 0% None 75%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MERCER GLOBAL ADVISORS INC /ADV holds $153,113,276 across 24 Diagnostics & Research names. MYGN ranks #20 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 51,463 $25,801,489
2 DHR
Danaher Corp /De/
 119,360 $22,735,692
3 DGX
Quest Diagnostics Inc
 104,301 $22,106,596
4 NTRA
Natera, Inc.
 63,607 $17,266,120
5 A
Agilent Technologies, Inc.
 93,804 $12,459,985
6 ILMN
Illumina, Inc.
 61,667 $10,842,908
7 MEDP
Medpace Holdings, Inc.
 13,882 $7,351,768
8 IDXX
Idexx Laboratories Inc /De
 13,662 $7,192,223

All Filings in MYGN

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $416,578 72,956
2026-03-31 $161,572 35,905
2025-12-31 $165,348 26,886
2025-09-30 $119,490 16,527